Dhamidhu Eratne
Grattan Street
Parkville, NSW 3052, Australia
Parkville, NSW 3052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Clarifications and response to "Validating plasma biomarkers for distinguishing neurodegenerative and psychiatric disorders" by Boccardi et al.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: March 01, 2026
Distinct contributions of cerebrospinal fluid biomarkers to cognitive impairment and neuropsychiatric symptoms in young-onset dementia.
Journal: Acta neuropsychiatrica
Published: December 23, 2025
Plasma p-tau217, NfL, GFAP diagnostic performance and biomarker profiles in Alzheimer's disease, frontotemporal dementia, and psychiatric disorders, in a prospective unselected neuropsychiatry memory clinic.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 10, 2025
Prevalence and Features of Misdiagnosis of Primary Psychiatric Disorders Among bvFTD Patients.
Journal: The Journal of neuropsychiatry and clinical neurosciences
Published: April 28, 2025
Plasma Glial Fibrillary Acidic Protein and Neurofilament Light Are Elevated in Bipolar Depression: Evidence for Neuroprogression and Astrogliosis.
Journal: Bipolar disorders
Published: March 21, 2025
Apathy and affective symptoms associated with elevated plasma neurofilament light but not p-tau181 in Alzheimer's disease.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: February 24, 2025
Biofluid biomarkers in distinguishing young-onset dementia from primary psychiatric disorders.
Journal: Current opinion in psychiatry
Published: January 31, 2025
Corrigendum to "Neurofilament light and glial fibrillary acidic protein in mood and anxiety disorders: A systematic review and meta-analysis" [Brain, Behavior, and Immunity 123 (2025) 1091-1102].
Journal: Brain, behavior, and immunity
Published: January 25, 2025
Blood biomarker profiles in young-onset neurocognitive disorders: A cohort study.
Journal: The Australian and New Zealand journal of psychiatry
Published: January 18, 2025
Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia.
Journal: The Australian and New Zealand journal of psychiatry
Published: January 04, 2025
Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort.
Journal: Journal of neurology
Published: September 21, 2024
Using cerebrospinal fluid biomarkers to diagnose Alzheimer's disease: an Australian perspective.
Journal: Frontiers in psychiatry
Published: August 30, 2024
Last Updated: 09/26/2026